Prosecution Insights
Last updated: May 29, 2026

Devicor Medical Products Inc.

4 pending office actions • 2 art units • 4 examiners • 0 of 4 (0%) have an AI response strategy ready • 8 patents granted in the last 365 days

Portfolio Summary

4
Total Pending OAs
2
Non-Final OAs
0
Final Rejections
2
Advisory / Quayle

Response Deadline Pressure

Based on the USPTO statutory response window for each pending office action. 3 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.

1
Overdue
0
Due this week
1
Due this month
1
Due in next 60 days
0
Due later

Deadline Fire Line

Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 3 of the docket's apps have a known mailing date.

-30dToday30d60d90d120d
Overdue (1)Due ≤ 30 days (1)Due ≤ 60 days (1)

Case Difficulty Mix

Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.

0
Hard (0%)
4
Medium (100%)
0
Easy (0%)
0
Unknown (0%)

Rejection Statute Mix

BucketCases
§103 only4 (100%)

Industry Mix

How the docket's pending cases split across USPTO tech-center bands.

0
Life Sciences
0% of docket
0
Information Tech
0% of docket
0
Communications
0% of docket
0
Semiconductors
0% of docket
4
Mechanical / Eng
100% of docket
0
Business / Other
0% of docket

Time-on-OA Estimate

Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.

40 h
Manual time on pending OAs
8 h
Time saved (low, 20%)
14 h
Time saved (mid, 35%)
0.3 wks
FTE-weeks freed (mid)

Top Examiners on this docket

ExaminerApps on this docketAllow rateInterview lift
DAVIS, AMELIE R 1 64.3% +34.9%
SHENG, CHAO 1 63.0% +27.4%
BASET, NESHAT 1 29.7% +28.0%
CHOI, YOUNHEE JEON 1 71.1% +48.1%

Hard Cases (1)

Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.

App #TitleExaminerDue in
18396989 INTEGRATED EXCESSIVE GAUSS NOTIFICATION FOR MRI BREAST BIOPSY SYSTEM BASET, NESHAT 1d overdue

Interview Candidates (4)

Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.

App #TitleExaminerDue in
18396989 INTEGRATED EXCESSIVE GAUSS NOTIFICATION FOR MRI BREAST BIOPSY SYSTEM BASET, NESHAT 1d overdue
19042233 BIOPSY SITE MARKER WIRELESS-POWERED VIBRATION SHENG, CHAO 21d
19171629 BIOPSY DEVICE WITH END DEPLOYMENT FOR MARKER DELIVERY DAVIS, AMELIE R 36d
18231921 BIOPSY SITE MARKER HAVING EXPANDABLE PORTION CHOI, YOUNHEE JEON

Top Art Units

Art UnitApps
3798 2
3797 2

Pending Office Actions

App #TitleExaminerArt UnitStatutesStatusDue inAIFiled
19171629 BIOPSY DEVICE WITH END DEPLOYMENT FOR MARKER DELIVERY DAVIS, AMELIE R 3798 §103 Non-Final OA 36d Pending Apr 07, 2025
19042233 BIOPSY SITE MARKER WIRELESS-POWERED VIBRATION SHENG, CHAO 3797 §103 Non-Final OA 21d Pending Jan 31, 2025
18396989 INTEGRATED EXCESSIVE GAUSS NOTIFICATION FOR MRI BREAST BIOPSY SYSTEM BASET, NESHAT 3798 §103 Non-Final OA 1d overdue Pending Dec 27, 2023
18231921 BIOPSY SITE MARKER HAVING EXPANDABLE PORTION CHOI, YOUNHEE JEON 3797 §103 Non-Final OA Pending Aug 09, 2023

Managing Devicor Medical Products Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month